Construction and Characterization of Adenovirus Vectors Encoding Aspartate-<i>β</i>-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma

<div>Images of vectors and brief flow chart of gateway cloning method. (a) Donor vector pDONR221. (b) Destination vector pAd CMV/V5-DEST. (c) The BP recombinant (attB × attP → attL × attR). (d) The LR recombinant (attL × attR → attB × attP).</div>

Journal of Immunology Research

fig1

Figure 1

Figure 1: Construction and Characterization of Adenovirus Vectors Encoding Aspartate-<i>β</i>-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma 

Figure 1 | Construction and Characterization of Adenovirus Vectors Encoding Aspartate-β-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma 